VASPORTA Trademark

Trademark Overview

On Tuesday, December 24, 2024, a trademark application was filed for VASPORTA with the United States Patent and Trademark Office. The USPTO has given the VASPORTA trademark a serial number of 98920986. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 25, 2025. This trademark is owned by Vascarta, Inc.. The VASPORTA trademark is filed in the Pharmaceutical Products category with the following description:

gel matrix for use in pharmaceutical preparations and substances for treating a wide range of acute and chronic inflammatory conditions
vasporta

General Information

Serial Number98920986
Word MarkVASPORTA
Filing DateTuesday, December 24, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements

Goods and Servicesgel matrix for use in pharmaceutical preparations and substances for treating a wide range of acute and chronic inflammatory conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVascarta, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Tuesday, December 24, 2024NEW APPLICATION ENTERED
Monday, March 10, 2025ASSIGNED TO EXAMINER
Monday, March 10, 2025NON-FINAL ACTION WRITTEN
Monday, March 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 10, 2025NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

vasporta acute chronic inflammatory conditions range wide pharmaceutical preparations substances treating